Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Gilead Sciences Incorporated
Woman and Man Max 99 years
Gilead Sciences Incorporated
Update Il y a 4 ans
A Phase 1B Study of the Safety and Pharmacokinetics of Ritonavir-Boosted Elvitegravir (GS-9137/r) Plus a Background Regimen (BR) in HIV-1 Infected, Antiretroviral Treatment-Experienced Adolescents
To evaluate the steady-state pharmacokinetics (PK) and confirm the dose of ritonavirboosted elvitegravir (GS-9137/r) in HIV-1 infected antiretroviral treatment-experienced adolescent subjects.
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2